"Cross Reactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen.
| Descriptor ID |
D003429
|
| MeSH Number(s) |
G12.122.281
|
| Concept/Terms |
Cross Reactions- Cross Reactions
- Cross Reaction
- Reaction, Cross
- Reactions, Cross
|
Below are MeSH descriptors whose meaning is more general than "Cross Reactions".
Below are MeSH descriptors whose meaning is more specific than "Cross Reactions".
This graph shows the total number of publications written about "Cross Reactions" by people in this website by year, and whether "Cross Reactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 6 | 6 |
| 2006 | 1 | 4 | 5 |
| 2007 | 1 | 5 | 6 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 5 | 6 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 8 | 10 |
| 2017 | 15 | 62 | 77 |
| 2018 | 13 | 68 | 81 |
| 2019 | 5 | 19 | 24 |
| 2020 | 7 | 75 | 82 |
| 2021 | 8 | 73 | 81 |
To return to the timeline, click here.
Below are the most recent publications written about "Cross Reactions" by people in Profiles.
-
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec; 10(1):664-676.
-
Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples. J Infect Dis. 2021 10 28; 224(8):1305-1315.
-
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination. Science. 2021 10 08; 374(6564):eabh1823.
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021 10 07; 138(14):1269-1277.
-
Incomplete IgG avidity maturation after seasonal coronavirus infections. J Med Virol. 2022 01; 94(1):186-196.
-
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity. mBio. 2021 08 31; 12(4):e0141521.
-
Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. JCI Insight. 2021 08 23; 6(16).
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. Lancet HIV. 2021 09; 8(9):e568-e580.
-
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021 09 17; 373(6561):1372-1377.
-
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).